METASTATIC NUT CARCINOMA
Clinical trials for METASTATIC NUT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NUT CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC NUT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy drug shows promise for rare, deadly cancer
Disease control Recruiting nowThis study tests a drug called cemiplimab in 15 people with NUT carcinoma, a rare and aggressive cancer that has spread or cannot be removed. The drug helps the immune system attack cancer cells. The goal is to see if it can help people live longer and shrink tumors.
Matched conditions: METASTATIC NUT CARCINOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
New drug cocktail aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis early-phase trial tests two drugs—ZEN003694 and abemaciclib—together in people with advanced NUT carcinoma, breast cancer, or other solid tumors that have spread or can't be removed. The main goals are to find the safest dose and see if the combination can shrink or stabiliz…
Matched conditions: METASTATIC NUT CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
New hope for rare cancer: drug combo targets NUT carcinoma
Disease control Recruiting nowThis study tests a new drug called ZEN003694 combined with standard chemotherapy for people with NUT carcinoma, a rare and fast-growing cancer. The goal is to find the safest dose and see if the combination shrinks tumors. About 36 adults with advanced or spreading NUT carcinoma …
Matched conditions: METASTATIC NUT CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:39 UTC